Guidelines for the evaluation, treatment, and management of the heterogeneous and progressive lysosomal storage disorder Morquio A syndrome (mucopolysaccharidosis IVA) have been published. These guidelines were developed during two expert meetings by an international panel of specialists in pediatrics, genetics, orthopedics, pulmonology, cardiology, and anesthesia with extensive experiencing in managing this condition. http://www.ncbi.nlm.nih.gov/pubmed/225346323?dopt=Abstract